Interval cancers after negative colonoscopy: Population-based case-control study

Gut

Volumn 61, Issue 11, 2012, Pages 1576-1582

  Brenner, Hermann ^a   Chang Claude, Jenny ^a   Seiler, Christoph M ^b   Hoffmeister, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCENDING COLON; CANCER GRADING; CANCER SCREENING; CECUM CANCER; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; INTERVAL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OCCULT BLOOD TEST; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR CLASSIFICATION;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; ODDS RATIO; RISK ASSESSMENT; SEX DISTRIBUTION; TIME FACTORS;

EID: 84864373288     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301531     Document Type: Article

References (31)

1. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73. (Pubitemid 43788104)
2. Brenner H, Chang-Claude J, Seiler CM, et al. Does a negative screening colonoscopy ever need to be repeated? Gut 2006;55:1145-50. (Pubitemid 44085683)
3. Lakoff J, Paszat LF, Saskin R, et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008;6:1117-21.
4. Imperiale TF, Glowinski EA, Lin-Cooper C, et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24.
5. Singh H, Nugent Z, Mahmud SM, et al. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010;105:663-73.
6. Singh H, Nugent Z, Demers AA, et al . Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010;105:2588-96.
7. Farrar WD, Sawhney MS, Nelson DB, et al. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006;4:1259-64. (Pubitemid 44512220)
8. Bressler B, Paszat LF, Vinden C, et al. Colonoscopic miss rates for right-sided colon cancer: population-based analysis. Gastroenterology 2004;127:452-6. (Pubitemid 39091893)
9. Bressler B, Paszat LF, Chen Z, et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007;132:96-102. (Pubitemid 46108740)
10. Hosokawa O, Shirasaki S, Kaizaki Y, et al. Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy 2003;35:506-10. (Pubitemid 36705642)
11. Leaper M, Johnston MJ, Barclay M, et al. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy 2004;36:499-503. (Pubitemid 38811617)
12. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancers. N Engl J Med 2010;362:1795-803.
13. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
14. Singh H, Nugent Z, Demers AA, et al . The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
15. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy. A population-based case-control study. Ann Intern Med 2011;154:22-30.
16. Anderson JC, Gonzales JD, Messina CR, et al. Factors that predict incomplete colonoscopy: thinner is not always better. Am J Gastroenterol 2000;95:2784-7.
17. Church JM. Complete colonoscopy: how often? And if not, why not? Am J Gastroenterol 1994;89:556-60. (Pubitemid 24106223)
18. Dafnis G, Granath F, Pahlman L, et al . Patient factors in uencing the completion rate in colonoscopy. Dig Liver Dis 2005;37:113-18. (Pubitemid 41070551)
19. Shah HA, Paszat LF, Saskin R, et al. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 2007;132:2297-303. (Pubitemid 46890860)
20. Rennert G, Rennert HS, Miron E, et al. Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2001;10:1165-8. (Pubitemid 33064304)
21. Steele RJC, McClements P, Watling C, et al. Interval cancers in a FOBT based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012;61:576-81.
22. Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010;105:2457-64.
23. Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 2010;304:2513-20.
24. Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010;8:858-64.
25. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-87.
26. Barault L, Charon-Barra C, Jooste V, et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008;68:8541-6.
27. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006;131:1700-5. (Pubitemid 44958526)
28. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010;105:1189-95.
29. Derwinger K, Kodeda K, Bexe-Lindskog E, et al . Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncol 2010;49:57-62.
30. Gertler R, Rosenberg R, Schuster T, et al. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy. Eur J Cancer 2009;45:2992-9.
31. Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 2007;166:130-6. (Pubitemid 47227287)